Trial intelligence / Profile preview

Liraglutide for acute stroke patients with impaired swallowing

2011-003572-36Phase 2Terminated

Sponsor
Royal Devon University Healthcare NHS Foundation Trust
Start
Dec 2011
Modality
Peptides
Countries
1
01

Overview

Phase 2, randomised, open-label trial of liraglutide in stroke (2 arms), sponsored by Royal Devon University Healthcare NHS Foundation Trust. Primary endpoints: Feasibility of definitive trial processes, Recruitment of target sample and 1 more. Started Dec 2011; status: terminated.

02

Drugs

03

Conditions

stroke

Beyond the preview

Go deeper on 2011-003572-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-003572-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call